| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c821adab4a045b72f43449186b20dfba |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2012-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6574a4d11e90d8340ee09a4ad75f12fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ecdec876d0a1f49853a3174ce84b82b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1954089c57cb47d279bc987cab1a1343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_090ce1a9efa88a5b8196749e6392171a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e929bab0360a988eb5a7ecde6fbc7a57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34fa62dc7762fd95a30be94917e8646a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fff32576d5f761993237ba8b2e7d3d1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4e4c1b070afed4892ebee77d99929f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f119a28c8aff683078aa9ecdf72bb0e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ad416b76061b508c044bacbeca324e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ce1d50674103da7a8f164d6116c6fa2 |
| publicationDate |
2015-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-103205422-B |
| titleOfInvention |
Method and detection kit for prediction of prostate cancer susceptibility |
| abstract |
The invention discloses a method and a detection kit for prediction of prostate cancer susceptibility. According to the invention, genomic DNA of a host cell is extracted and the genotype of site rs9400968 on a fourth intron of the RFX6 gene of a subject is determined so as to predicate susceptibility of the subject to a prostate cancer; if the genotype of the rs9400968 on the intron of the RFX6 gene is GG, the subject has highest susceptibility, and if the genotype of the rs9400968 is AG or AA, the subject has low susceptibility. The invention has the following advantages: correlation between the rs9400968 gene polymorphism site and the prostate cancer is elaborated for the first time; the method for predicting prostate cancer susceptibility is provided; and the method is applicable to early prevention and diagnosis and auxiliary diagnosis of the prostate cancer and can also be used for research and development of a novel drug. |
| priorityDate |
2012-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |